Back to funds
View filing
First Light Asset Management, LLC
hedge fundUpdated 27 days agoManaged by First Light Asset Management, Llc • Latest filing Q2 2026
Portfolio value
$1.6B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
0.2%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.1B |
| Q2 2023 | $1.3B |
| Q3 2023 | $1.1B |
| Q4 2023 | $1.2B |
| Q1 2024 | $1.3B |
| Q2 2024 | $1.1B |
| Q3 2024 | $1.2B |
| Q4 2024 | $1B |
| Q1 2025 | $875.7M |
| Q2 2025 | $771.3M |
| Q3 2025 | $1.1B |
| Q4 2025 | $1.3B |
| Q1 2026 | $1.1B |
| Q2 2026 | $1.6B |
Top holdings
31 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | N NEO NEOGENOMICS INC | $179.2M | 12.28M | 10.89% | — |
| 2 | S SIBN SI-BONE INC | $132.6M | 8.13M | 8.06% | — |
| 3 | A AXGN AXOGEN INC | $126.9M | 2.75M | 7.72% | — |
| 4 | A APGE APOGEE THERAPEUTICS INC | $123.5M | 930.3K | 7.50% | — |
| 5 | P PVLA PALVELLA THERAPEUTICS INC | $118M | 771.9K | 7.17% | — |
| 6 | T TWST TWIST BIOSCIENCE CORPORATION | $74.9M | 727.9K | 4.55% | — |
| 7 | E ELVN ENLIVEN THERAPEUTICS INC | $69.1M | 1.36M | 4.20% | — |
| 8 | G GH GUARDANT HEALTH | $66.3M | 441.6K | 4.03% | — |
| 9 | M MASS 908 DEVICES INC | $54.7M | 6.28M | 3.32% | — |
| 10 | A AMLX AMYLYX PHARMACEUTICALS INC | $54.3M | 3.02M | 3.30% | — |
| 11 | W WGSWW GENEDX HOLDINGS CORP | $53.8M | 783.9K | 3.27% | — |
| 12 | S SLP SIMULATIONS PLUS INC | $51.1M | 2.79M | 3.11% | — |
| 13 | T TNDM TANDEM DIABETES CARE INC | $51.1M | 3.38M | 3.10% | — |
| 14 | C CRNX CRINETICS PHARMACEUTICALS INC | $50.9M | 1.36M | 3.10% | — |
| 15 | N NPCE NEUROPACE INC | $45.5M | 2.86M | 2.76% | — |
| 16 | E EWTX EDGEWISE THERAPEUTICS INC | $44.5M | 1.10M | 2.70% | — |
| 17 | A ADI ANAPTYS BIO INC | $39.3M | 582.0K | 2.39% | — |
| 18 | T TRVI TREVI THERAPEUTICS INC | $39.1M | 2.10M | 2.38% | — |
| 19 | S SEPN SEPTERNA INC | $32.3M | 963.3K | 1.96% | — |
| 20 | T TLSIW TRISALUS LIFE SCIENCES INC | $29.8M | 6.55M | 1.81% | — |